EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Updates on germline predisposition in pediatric hematologic malignancies: What is the role of flow cytometry?

Nadine Demko iD, Julia T Geyer

Cytometry Part B: Clinical Cytometry · 2024

DOI: 10.1002/cyto.b.22192 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cytometry Part B: Clinical Cytometry, 2024. Verfasst von Nadine Demko und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA. Hauptthemen laut MEDLINE: Flow Cytometry, Hematologic Neoplasms, Germ-Line Mutation, Immunophenotyping. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hematologic neoplasms with germline predisposition have been increasingly recognized as a distinct category of tumors over the last few years. As such, this category was added to the World Health Organization (WHO) 4th edition as well as maintained in the WHO 5th edition and International Consensus Classification (ICC) 2022 classification systems. In practice, these tumors require a high index of suspicion and confirmation by molecular testing. Flow cytometry is a cost‐effective diagnostic tool that is routinely performed on peripheral blood and bone marrow samples. In this review, we sought to summarize the current body of research correlating flow cytometric immunophenotype to assess its utility in diagnosis of and clinical decision making in germline hematologic neoplasms. We also illustrate these findings using cases mostly from our own institution. We review some of the more commonly mutated genes, including CEBPA, DDX41, RUNX1, ANKRD26, GATA2 , Fanconi anemia, Noonan syndrome, and Down syndrome. We highlight that flow cytometry may have a role in the diagnosis ( GATA2 , Down syndrome) and screening ( CEBPA ) of some germline predisposition syndromes, although appears to show nonspecific findings in others ( DDX41, RUNX1 ). In many of the others, such as ANKRD26 , Fanconi anemia, and Noonan syndrome, further studies are needed to better understand whether specific flow cytometric patterns are observed. Ultimately, we conclude that further studies such as large case series and organized data pipelines are needed in most germline settings to better understand the flow cytometric immunophenotype of these neoplasms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Flow CytometryHematologic NeoplasmsGerm-Line MutationImmunophenotypingGenetic Predisposition to DiseaseHumansChildCore Binding Factor Alpha 2 SubunitCCAAT-Enhancer-Binding Proteins

Stichwörter der Autor:innen

germline predispositionhematologic malignancieshematopathologymyeloid neoplasmspediatrics

Substanzen

Core Binding Factor Alpha 2 SubunitCCAAT-Enhancer-Binding ProteinsCEBPA protein, human

Autor:innen und Institutionen

  • Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA.
  • Department of Pathology, McGill University, Montréal, Québec, Canada.

ORCID-Profile: Nadine Demko

Zitieren

APA

Demko, N., & Geyer, J. T. (2024). Updates on germline predisposition in pediatric hematologic malignancies: What is the role of flow cytometry?. Cytometry Part B: Clinical Cytometry. https://doi.org/10.1002/cyto.b.22192

Vancouver

Demko N, Geyer JT. Updates on germline predisposition in pediatric hematologic malignancies: What is the role of flow cytometry?. Cytometry Part B: Clinical Cytometry. 2024. doi:10.1002/cyto.b.22192

BibTeX
@article{Demko2024,
  author = {Demko, Nadine and Geyer, Julia T},
  title = {Updates on germline predisposition in pediatric hematologic malignancies: What is the role of flow cytometry?},
  journal = {Cytometry Part B: Clinical Cytometry},
  year = {2024},
  doi = {10.1002/cyto.b.22192}
}
Kostenlos starten →